50
Alzheimers Drug Discovery Foundation
Science & Technology · New York, New York
57 W 57Th St Ste 904, New York, NY 10019-2819
EIN: 201082179· Founded: Sep 2005· 21 years active· Filing Year: 2023
Annual Revenue
$37.7M
Total Expenses
$61.9M
Total Assets
$324.2M
Program Spending
7%
of expenses go to programs
Compensation & Payroll
Total Officer Compensation
$1.7M
2.8% of total expenses
All officers, directors, and key employees combined
Other Salaries & Wages
$4.8M
Total Payroll
$6.5M
10% of total expenses
Where the Money Goes
7%
Programs: 7%
Payroll: 10%
Other overhead: 93%
Program Revenue$4.2M (11%)
Total Expenses$61.9M (100%)
Payroll$6.5M (10%)
Overhead (non-program)93%
Trust Score Breakdown
Program Spending Ratio
7% of expenses go to programs
Revenue & Stability
$37.7M annual revenue
Executive Compensation
$1.7M total officer comp (2.8% of expenses)
Filing Recency
Most recent filing: 2023
Asset Strength
$324.2M in assets
Data from IRS Form 990 filing (2023). Trust scores are calculated from public financial data and do not constitute endorsement or investment advice.